A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational

E Warbrick1

  • 1Department of Surgery and Molecular Oncology, University of Dundee, Ninewells Hospital and Medical School, UK. c.warbrick@dundee.ac.uk

Oncogene
|January 13, 2006
PubMed
Summary

Researchers developed peptide aptamers that inhibit proliferating cell nuclear antigen (PCNA) function, offering potential for new antiproliferative therapies.